Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions.Psychedelic medicine (New Rochelle, N.Y.) · 2025-12-01Adverse reactions among psychedelic users: Norwegian validation of the Challenging Experience Questionnaire.Journal of psychiatric research · 2025-09-01A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.Psychedelic medicine (New Rochelle, N.Y.) · 2025-03-01Psychedelics and substance use disorder treatment.International review of neurobiology · 2025-01-01Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous RE104: A Double-Blind, Randomized, Single Ascending Dose Placebo-Controlled Study.Journal of clinical psychopharmacology · 2025-01-01The Mystical Experience Questionnaire 4-Item and Challenging Experience Questionnaire 7-Item.Psychedelic medicine (New Rochelle, N.Y.) · 2024-03-01IUPHAR-review: The integration of classic psychedelics into current substance use disorder treatment models.Pharmacological research · 2024-01-01Beliefs and Perceived Barriers Regarding Psychedelic-assisted Therapy in a Pilot Study of Service Members and Veterans With a History of Traumatic Brain Injury.Military medicine · 2023-11-03Assessing potential of psilocybin for depressive disorders.Expert opinion on investigational drugs · 2023-01-01Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey.Frontiers in psychiatry · 2023-01-01Verbal behavior related to drug reinforcement in polysubstance cannabis users: Comparison across drugs.Experimental and clinical psychopharmacology · 2022-04-01Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.Journal of psychopharmacology (Oxford, England) · 2022-02-01Psychedelics and health behaviour change.Journal of psychopharmacology (Oxford, England) · 2022-01-01Human behavioral pharmacology of psychedelics.Advances in pharmacology (San Diego, Calif.) · 2022-01-01Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation.Current topics in behavioral neurosciences · 2022-01-01Psychedelic Identity Shift: A Critical Approach to Set And Setting.Kennedy Institute of Ethics journal · 2022-01-01Psychedelics and Psychotherapy: Cognitive-Behavioral Approaches as Default.Frontiers in psychology · 2022-01-01Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programs.The International journal on drug policy · 2021-12-01Psychedelics and Consciousness: Distinctions, Demarcations, and Opportunities.The international journal of neuropsychopharmacology · 2021-08-20Predicting changes in substance use following psychedelic experiences: natural language processing of psychedelic session narratives.The American journal of drug and alcohol abuse · 2021-07-04Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.JAMA psychiatry · 2021-05-01Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches.Journal of psychopharmacology (Oxford, England) · 2021-04-01Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan.Psychopharmacology · 2020-08-01Editorial: Hallucinogens and Entactogens: Establishing a New Class of Drugs?Frontiers in psychiatry · 2020-01-01Cessation and reduction in alcohol consumption and misuse after psychedelic use.Journal of psychopharmacology (Oxford, England) · 2019-09-01Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.Pharmacology & therapeutics · 2019-05-01Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT.PloS one · 2019-01-01Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey.Frontiers in psychiatry · 2019-01-01The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act.Neuropharmacology · 2018-11-01Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition.Psychopharmacology · 2018-10-01Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts.Journal of psychopharmacology (Oxford, England) · 2018-07-01Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences.Psychopharmacology · 2018-02-01Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors.Journal of psychopharmacology (Oxford, England) · 2018-01-01Neuroticism is associated with challenging experiences with psilocybin mushrooms.Personality and individual differences · 2017-10-15An online survey of tobacco smoking cessation associated with naturalistic psychedelic use.Journal of psychopharmacology (Oxford, England) · 2017-07-01Potential Therapeutic Effects of Psilocybin.Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics · 2017-07-01Psychedelics as Medicines: An Emerging New Paradigm.Clinical pharmacology and therapeutics · 2017-02-01Long-term follow-up of psilocybin-facilitated smoking cessation.The American journal of drug and alcohol abuse · 2017-01-01Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences.Journal of psychopharmacology (Oxford, England) · 2016-12-01The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms.Journal of psychopharmacology (Oxford, England) · 2016-12-01Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.Journal of psychopharmacology (Oxford, England) · 2016-12-01Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans.The international journal of neuropsychopharmacology · 2016-07-01Classic hallucinogens in the treatment of addictions.Progress in neuro-psychopharmacology & biological psychiatry · 2016-01-04Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin.Journal of psychopharmacology (Oxford, England) · 2015-11-01Psilocybin, psychological distress, and suicidality.Journal of psychopharmacology (Oxford, England) · 2015-09-01Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population.Journal of psychopharmacology (Oxford, England) · 2015-03-01Can psychedelic compounds play a part in drug dependence therapy?The British journal of psychiatry: the journal of mental science · 2015-01-01Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction.Journal of psychopharmacology (Oxford, England) · 2014-11-01Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision.Journal of psychopharmacology (Oxford, England) · 2014-01-01Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction.Current drug abuse reviews · 2014-01-01Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin.Journal for the scientific study of religion · 2012-12-01High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens.Psychopharmacology · 2012-09-01Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers.Drug and alcohol dependence · 2012-06-01Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects.Psychopharmacology · 2011-12-01Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness.Journal of psychopharmacology (Oxford, England) · 2011-11-01